| Primary |
| Chronic Obstructive Pulmonary Disease |
41.7% |
| Emphysema |
18.1% |
| Asthma |
11.1% |
| Dyspnoea |
6.9% |
| Pneumonia |
5.6% |
| Lung Neoplasm Malignant |
2.8% |
| Wheezing |
2.8% |
| Bronchial Hyperactivity |
1.4% |
| Bronchospasm |
1.4% |
| Fibrosis |
1.4% |
| Lung Disorder |
1.4% |
| Nasopharyngitis |
1.4% |
| Pulmonary Congestion |
1.4% |
| Pulmonary Granuloma |
1.4% |
| Shortness Of Breath |
1.4% |
|
| Tremor |
21.3% |
| Pharmaceutical Product Complaint |
12.8% |
| Dyspnoea |
8.5% |
| Heart Rate Increased |
8.5% |
| Drug Ineffective |
6.4% |
| Candidiasis |
4.3% |
| Dysgeusia |
4.3% |
| Pneumonia |
4.3% |
| Staphylococcal Infection |
4.3% |
| Swelling |
4.3% |
| Adverse Event |
2.1% |
| Bronchospasm |
2.1% |
| Chest Pain |
2.1% |
| Completed Suicide |
2.1% |
| Death |
2.1% |
| Decreased Appetite |
2.1% |
| Drug Dispensing Error |
2.1% |
| Epistaxis |
2.1% |
| Flushing |
2.1% |
| Glossodynia |
2.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
56.3% |
| Chronic Obstructive Pulmonary Disease |
14.6% |
| Emphysema |
7.0% |
| Product Used For Unknown Indication |
5.6% |
| Depression |
5.2% |
| Asthma |
3.0% |
| Dyspnoea |
1.7% |
| Glioblastoma Multiforme |
1.7% |
| Uterine Leiomyosarcoma |
1.5% |
| Lung Disorder |
0.6% |
| Myelodysplastic Syndrome |
0.6% |
| Inflammation |
0.4% |
| Lower Respiratory Tract Infection |
0.4% |
| Smoking Cessation Therapy |
0.4% |
| Wheezing |
0.4% |
| Arrhythmia |
0.2% |
| Asbestosis |
0.2% |
| Cardiac Failure Congestive |
0.2% |
| Hormone Replacement Therapy |
0.2% |
| Immunodeficiency Common Variable |
0.2% |
|
| Tremor |
11.1% |
| Visual Disturbance |
11.1% |
| Postoperative Infection |
9.9% |
| Dyspnoea |
7.4% |
| Hyponatraemia |
7.4% |
| Drug Ineffective |
6.2% |
| Wheezing |
6.2% |
| Candidiasis |
3.7% |
| Dry Mouth |
3.7% |
| Dysgeusia |
3.7% |
| Fatigue |
3.7% |
| Post Procedural Infection |
3.7% |
| Therapeutic Response Decreased |
3.7% |
| Weight Increased |
3.7% |
| Asthma |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Drug Effect Decreased |
2.5% |
| Insomnia |
2.5% |
| Nervousness |
2.5% |
| Paraesthesia Oral |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
25.3% |
| Product Used For Unknown Indication |
25.2% |
| Chronic Obstructive Pulmonary Disease |
12.1% |
| Asthma |
8.5% |
| Hypertension |
4.3% |
| Pain |
3.8% |
| Anxiety |
2.1% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Depression |
1.9% |
| Osteoporosis |
1.8% |
| Emphysema |
1.8% |
| Dyspnoea |
1.7% |
| Atrial Fibrillation |
1.5% |
| Diabetes Mellitus |
1.3% |
| Pulmonary Arterial Hypertension |
1.2% |
| Constipation |
1.1% |
| Nausea |
1.1% |
| Smoking Cessation Therapy |
1.1% |
| Prophylaxis |
1.1% |
| Rheumatoid Arthritis |
1.0% |
|
| Pneumonia |
12.4% |
| Vomiting |
10.3% |
| Dyspnoea |
8.8% |
| Death |
7.6% |
| Weight Decreased |
6.9% |
| Wheezing |
6.9% |
| Weight Increased |
4.6% |
| Respiratory Failure |
4.5% |
| Urinary Tract Infection |
4.2% |
| Drug Ineffective |
3.9% |
| Chronic Obstructive Pulmonary Disease |
3.4% |
| Pulmonary Embolism |
3.4% |
| Pruritus |
3.2% |
| Tremor |
3.2% |
| Oedema Peripheral |
3.0% |
| Nausea |
2.9% |
| Sepsis |
2.9% |
| Pyrexia |
2.7% |
| Vision Blurred |
2.7% |
| Pharmaceutical Product Complaint |
2.6% |
|
